Correlation Between Neurocrine Biosciences and Benchmark Bankshares

Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and Benchmark Bankshares at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and Benchmark Bankshares into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neurocrine Biosciences and Benchmark Bankshares, you can compare the effects of market volatilities on Neurocrine Biosciences and Benchmark Bankshares and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of Benchmark Bankshares. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and Benchmark Bankshares.

Diversification Opportunities for Neurocrine Biosciences and Benchmark Bankshares

0.88

Correlation Coefficient

Neurocrine Biosciences  Benchmark Bankshares

Very poor diversification

The 3 months correlation between Neurocrine and Benchmark is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and Benchmark Bankshares in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Benchmark Bankshares and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with Benchmark Bankshares. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Benchmark Bankshares has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and Benchmark Bankshares go up and down completely randomly.

Pair Corralation between Neurocrine Biosciences and Benchmark Bankshares

Given the investment horizon of 90 days Neurocrine Biosciences is expected to generate 1.46 times less return on investment than Benchmark Bankshares. But when comparing it to its historical volatility, Neurocrine Biosciences is 1.2 times less risky than Benchmark Bankshares. It trades about 0.02 of its potential returns per unit of risk. Benchmark Bankshares is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  2,250  in Benchmark Bankshares on September 26, 2024 and sell it today you would earn a total of  350.00  from holding Benchmark Bankshares or generate 15.56% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	88.1%
Values	Daily Returns

Neurocrine Biosciences  vs.  Benchmark Bankshares

Neurocrine Biosciences

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Neurocrine Biosciences are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady forward indicators, Neurocrine Biosciences showed solid returns over the last few months and may actually be approaching a breakup point.

Benchmark Bankshares

Risk-Adjusted Performance

18 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Benchmark Bankshares are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of very abnormal fundamental drivers, Benchmark Bankshares displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Neurocrine Biosciences and Benchmark Bankshares

The main advantage of trading using opposite Neurocrine Biosciences and Benchmark Bankshares positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, Benchmark Bankshares can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Benchmark Bankshares will offset losses from the drop in Benchmark Bankshares' long position.

The idea behind Neurocrine Biosciences and Benchmark Bankshares pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.